Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jama Pitman Insider Profile
4 Followers
Jama Pitman, SVP, Chief Development Officer at Deciphera Pharmaceuticals, holds 68.03K shares in Deciphera Pharmaceuticals (Ticker: DCPH).
Jama Pitman Deciphera Pharmaceuticals (DCPH)SVP, Chief Development Officer
Deciphera Pharmaceuticals (DCPH)
SVP, Chief Development Officer
Ranked #94,782 out of 98,743 Corporate Insiders
Profitable Transactions
1 out of 9 Profitable Transactions
Average Return
-52.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
SVP, Chief Development Officer
Roles that Jama Pitman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 19, 2023 - Jan 19, 2024
Return:+27.30%
The most profitable trade made by Jama Pitman
Jama Pitman's Trading History
List of latest transactions for each holding click on a transaction to see Jama Pitman's performance on stock
You May Also Like
Jama Pitman insider profile FAQ
What is the percentage of profitable transactions made by Jama Pitman?
The percentage of profitable transactions made by Jama Pitman is 11%.
What is the average return per transaction made by Jama Pitman?
The average return per transaction made by Jama Pitman is -52.30%.
What stocks does Jama Pitman hold?
Jama Pitman holds: DCPH stocks.
What was Jama Pitman’s latest transaction?
Jama Pitman latest transaction was an Uninformative Buy of ―.
What was Jama Pitman's most profitable transaction?
Jama Pitman’s most profitable transaction was an Informative Sell of DCPH stock on January 19, 2023. The return on the trade was 27.30%.
What is Jama Pitman's role in Deciphera Pharmaceuticals?
Jama Pitman's role in Deciphera Pharmaceuticals is SVP, Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.